Elanco Animal Health Inc (ELAN) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US28414H1032
Elanco Animal Health Inc financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 4.72 bn USD |
| Gross profit | 2.59 bn USD |
| EBIT | -267.00 m USD |
| Net income | -232.00 m USD |
| Diluted EPS – continuing operations | -0.47 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Elanco Animal Health Inc
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.
More stocks
- Freedom Holding Corp. (FRHC)
- Samsung Fire And Marine Ins Pref (000815.KS)
- Saputo Inc (SAP.TO)
- Smurfit Kappa Group PLC (SK3.IR)
- CPFL Energia S.A (CPFE3.SA)
- Chiba Bank Ltd (8331.T)
- WATSCO INC (WSO)
- Essential Utilities, Inc. (WTRG)
- Ally Financial Inc. (ALLY)
- Anhui Tongguan Copper Foil Group Co. Ltd. (301217.SZ)
- Toray Industries Inc (3402.T)
- Magnum Ice Cream Company NV (MICC.AS)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.